![Antibodies | Free Full-Text | Antibody Structure and Function: The Basis for Engineering Therapeutics Antibodies | Free Full-Text | Antibody Structure and Function: The Basis for Engineering Therapeutics](https://pub.mdpi-res.com/antibodies/antibodies-08-00055/article_deploy/html/images/antibodies-08-00055-g006.png?1577720963)
Antibodies | Free Full-Text | Antibody Structure and Function: The Basis for Engineering Therapeutics
![An Antibody to the Aggregated Synthetic Prion Protein Peptide (PrP106–126) Selectively Recognizes Disease‐Associated Prion Protein (PrPSc) from Human Brain Specimens - Jones - 2009 - Brain Pathology - Wiley Online Library An Antibody to the Aggregated Synthetic Prion Protein Peptide (PrP106–126) Selectively Recognizes Disease‐Associated Prion Protein (PrPSc) from Human Brain Specimens - Jones - 2009 - Brain Pathology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a7cd386f-8987-4432-8013-bc7506f13189/bpa_181_f2.gif)
An Antibody to the Aggregated Synthetic Prion Protein Peptide (PrP106–126) Selectively Recognizes Disease‐Associated Prion Protein (PrPSc) from Human Brain Specimens - Jones - 2009 - Brain Pathology - Wiley Online Library
![Behavioral deficits, learning impairment, and enhanced hippocampal excitability in co-isogenic PrnpZH3/ZH3 mice | bioRxiv Behavioral deficits, learning impairment, and enhanced hippocampal excitability in co-isogenic PrnpZH3/ZH3 mice | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/10/26/2021.02.20.432083/F3.large.jpg)
Behavioral deficits, learning impairment, and enhanced hippocampal excitability in co-isogenic PrnpZH3/ZH3 mice | bioRxiv
![Behavioral deficits, learning impairment, and enhanced hippocampal excitability in co-isogenic PrnpZH3/ZH3 mice | bioRxiv Behavioral deficits, learning impairment, and enhanced hippocampal excitability in co-isogenic PrnpZH3/ZH3 mice | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/10/26/2021.02.20.432083/F6.large.jpg)
Behavioral deficits, learning impairment, and enhanced hippocampal excitability in co-isogenic PrnpZH3/ZH3 mice | bioRxiv
![Behavioral deficits, learning impairment, and enhanced hippocampal excitability in co-isogenic PrnpZH3/ZH3 mice | bioRxiv Behavioral deficits, learning impairment, and enhanced hippocampal excitability in co-isogenic PrnpZH3/ZH3 mice | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/10/26/2021.02.20.432083/F4.large.jpg)
Behavioral deficits, learning impairment, and enhanced hippocampal excitability in co-isogenic PrnpZH3/ZH3 mice | bioRxiv
Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy | PLOS Biology
The European antibody network's practical guide to finding and validating suitable antibodies for research
![Antibodies | Free Full-Text | Antibody Structure and Function: The Basis for Engineering Therapeutics Antibodies | Free Full-Text | Antibody Structure and Function: The Basis for Engineering Therapeutics](https://pub.mdpi-res.com/antibodies/antibodies-08-00055/article_deploy/html/images/antibodies-08-00055-g005b.png?1577720961)
Antibodies | Free Full-Text | Antibody Structure and Function: The Basis for Engineering Therapeutics
The European antibody network's practical guide to finding and validating suitable antibodies for research
Behavioral deficits, learning impairment, and enhanced hippocampal excitability in co-isogenic PrnpZH3/ZH3 mice
![Behavioral deficits, learning impairment, and enhanced hippocampal excitability in co-isogenic PrnpZH3/ZH3 mice | bioRxiv Behavioral deficits, learning impairment, and enhanced hippocampal excitability in co-isogenic PrnpZH3/ZH3 mice | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/10/26/2021.02.20.432083/F2.large.jpg)
Behavioral deficits, learning impairment, and enhanced hippocampal excitability in co-isogenic PrnpZH3/ZH3 mice | bioRxiv
Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy | PLOS Biology
Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy | PLOS Biology
Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy
![An Antibody to the Aggregated Synthetic Prion Protein Peptide (PrP106–126) Selectively Recognizes Disease‐Associated Prion Protein (PrPSc) from Human Brain Specimens - Jones - 2009 - Brain Pathology - Wiley Online Library An Antibody to the Aggregated Synthetic Prion Protein Peptide (PrP106–126) Selectively Recognizes Disease‐Associated Prion Protein (PrPSc) from Human Brain Specimens - Jones - 2009 - Brain Pathology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/21fb6d9c-a47c-4117-b8f0-35192ecdc709/bpa_181_f1.gif)